glp-1 receptor agonists in pediatric and adolescent obesity Role of Obesity: Benefits, Risks, Approaches to Patient Selection | Current Reports GLP-1 agonists in pediatric obesity:

Diabetes Care 48 , 846859 (2025)

Gastrointestinal symptoms and occasional psychiatric concerns require monitoring

"If you are increasing the protein, you're decreasing the rapidly absorbable carbohydrates, you're decreasing fat, excess calories, and sugar," says Kessler

Effects of GLP-1 receptor agonists on bone mineral density in patients with type 2 diabetes mellitus: A 52-week clinical study

This is further supported by the near-complete absence of cardiac Glp1r mRNA in Glp1r Tie2/ mice (57), suggesting that mouse cardiac Glp1r expression is primarily contributed by endothelial cells and/or immune cells

There is only failure in pushing through severe symptoms until you quit entirely